Dual Kinase Inhibitor Shows Early Promise in Multiple Cancers
CYC065, an inhibitor of CDK2 and CDK9 kinases, has inhibited tumor growth in some patients with advanced cancers
CYC065, an inhibitor of CDK2 and CDK9 kinases, has inhibited tumor growth in some patients with advanced cancers
The personal genomics product will focus on 59 genes identified by the American College of Medical Genetics and Genomics
How a researcher at UC San Diego is elucidating the role of microglial dysfunction in brain trauma and disorders
AACR and CRUK, two of the biggest cancer research committees around the globe to join force to aid the development of cancer therapeutics
The highly anticipated platform was launched by Repositive at AACR annual meeting
The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy
Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer
The HeraSafe 2030i BSC is designed to optimize contamination control and accelerate productivity across challenging cell culture applications
Team heading to Chicago, USA, to interview scientists at the forefront of cancer research and report on the newest technologies
Managing director believes the new Pharos V8 Instrument may revolutionize PCR techniques